-

EU Regulations for Digital Medical Devices with AI Components Specialist Course | A Basket Full of Requirements - What Does a Manufacturer Need to Consider? (ONLINE EVENT: October 7, 2025) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "The EU Regulations for Digital Medical Devices with AI Components - A Basket Full of Requirements - What Does a Manufacturer Need to Consider?" training has been added to ResearchAndMarkets.com's offering.

This compact 4-hour specialist course provides manufacturers, developers and quality managers with a systematic overview of the regulatory requirements that must be observed when developing and placing AI-based medical software on the market in Europe.

In addition to EU MDR 2017/745, numerous other EU regulations and national regulations apply to the development, approval and documentation of digital medical devices with AI components, the sheer number of which can make even well-informed manufacturers and developers lose track. In addition, various legal deadlines expire or have already expired by 2031, with further requirements to be met with each deadline. For example, the AI Act is already legally binding and applicable, while the regulations on the European Health Data Space (EHDS) have several transitional periods.

It is also often unclear what exactly the legislator means by a digital medical device and how an AI component affects the requirements. It should also be borne in mind that digital products that become part of a critical infrastructure must comply with the NIS2 Directive or the KRITIS Umbrella Act. This seminar systematically guides you through the requirements for digital medical devices with AI components in the regulatory role of manufacturer and contract developer. It provides you with a structured approach on how to comply with and apply the current and future regulations.

The development and marketing of digital medical devices with AI components is subject to numerous European regulations. In addition to the EU Medical Device Regulation (MDR), the AI Act, data protection requirements (GDPR) and standards such as IEC 62304, ISO 14971 and ISO/IEC 42001 are increasingly coming into focus.

Why Should You Attend

You should attend this webinar to understand, what are the changes to the previous ISO 14971 and how to implement the changes in your risk management file in a simple and quick way. Your implementation time can be shorter with a good plan and approach and need smart ideas to reach the right level to pass the expectation by your certification company or notified body.

Who Should Attend:

  • Manufacturers and developers of digital medical devices
  • Regulatory affairs managers
  • Quality managers
  • Technical project managers and software architects

Key Topics Covered:

What is a digital medical device with an AI component?

  • Definition of the term from the perspective of various applicable regulations.
  • Comparison of different terms and definitions.
  • Definition and differentiation from digital health applications (DiGA)

Where can the requirements for digital medical devices be found in the EU MDR 2017/745?

which other EU regulations and EU directives apply?

  • AI Act, Data Act, Data Governance Act, EHDS Act, GDPR, NIS-2, new Product Liability Directive.

Which mandatory harmonized standards apply?

How do the various regulations interact and what impact does this have on the development and approval process and product documentation?

Transitional periods

  • When do which transition periods expire and what does this mean for manufacturers and operators of digital medical devices?
  • A parallel overview of the deadlines for all the regulations discussed here

Speakers:

Prof. Dr. h.c. Frank Stein

Senior Medical Device Expert

Nemius Consulting GmbH

Dr. h.c. Frank Stein, medical engineer, medical engineering experience since 25 years, clinical and research experience in cardiac surgery and cardiology, industrial experience in ophthalmology, neurology, traumatology and dental implants, active implants, active devices, international project and regulatory consulting experience in Europe, North-America, Asia, Australia, Arabic Countries, Latin-America.

For more information about this training visit https://www.researchandmarkets.com/r/4kqcev

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Research and Markets


Release Versions

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

Sustainable Certification Market: Market Insights and Forecasts 2021-2024 & 2025-2031 | Competitive Analysis of SGS, Bureau Veritas, TUV, Intertek, UL Solutions, DNV, Eurofins Scientific - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Sustainable Certification Market (2025 Edition): Analysis Certification Type, By Industry Vertical, By End-User: Market Insights and Forecast (2021-2031)" report has been added to ResearchAndMarkets.com's offering. The Global Sustainable Certification market showcased growth at a CAGR of 13.29% during 2021-2024. The market was valued at USD 6.85 Billion in 2024 which is expected to reach USD 21.33 Billion in 2031. This report provides a complete analysis for the hi...

United States Smart Pills (Capsule Endoscopy, Patient Monitoring, Drug Delivery) Market Research, Drug Delivery Innovations & Forecast Report 2025-2033 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "United States Smart Pills Market - Drug Delivery Innovation & Forecast 2025-2033" report has been added to ResearchAndMarkets.com's offering. United States Smart Pills Market is expected to reach US$ 4.13 billion by 2033 from US$ 1.53 billion in 2024, with a CAGR of 11.66% from 2025 to 2033 Rising demand for minimally invasive diagnostics, an increase in gastrointestinal disorders, an aging population, improvements in wireless capsule technology, rising healthc...

Germany Commercial Construction Industry Report 2025-2034 | Digitalisation and Modernisation Propel Growth - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Germany Commercial Construction Market Report and Forecast 2025-2034" report has been added to ResearchAndMarkets.com's offering. The Germany commercial construction market size is estimated to grow at a CAGR of 4.30% in the forecast period of 2025-2034. The major market drivers include increasing urbanisation in Germany and rising investments in the construction sector. Commercial construction refers to the construction, remodelling, and renovation of a building o...
Back to Newsroom